INSIDER · CIK 1221590
Bienaime Jean Jacques
Director at Keros Therapeutics, Inc. (KROS) · Director at Ascendis Pharma A/S (ASND)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$503KBought on the market
$0.00Sold on the market
2Companies
Aug 19, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 202616:10 | Aug 17, 2026 | KROSKeros Therapeutics, Inc. | Director | P · Buy10b5-1 | $10.27 | +1,000 | 19,592 | +5% | +$10K | -14.6% | +10.6% |
| Aug 18, 202621:02 | Aug 14, 2026 | ASNDAscendis Pharma A/S | Director | P · Buy | $246.33 | +2,000 | 2,900 | +222% | +$493K | -11.1% | +2.7% |